We are live on ! Find out more
HWAM

Hennion & Walsh Asset Management Portfolio holdings

AUM $3.5B
1-Year Est. Return 41.95%
This Fund
S&P 500
This Quarter Est. Return
+7.26%
1 Year Est. Return
+41.95%
3 Year Est. Return
+93.92%
5 Year Est. Return
+100.55%
10 Year Est. Return
AUM
$1.87B
AUM Growth
+$120M
Cap. Flow
+$26.2M
Cap. Flow %
1.4%
Top 10 Hldgs %
17.39%
Holding
896
New
80
Increased
374
Reduced
377
Closed
56

Sector Composition

Rank Sector Weight
1 Healthcare 12.28%
2 Financials 10.3%
3 Technology 9.47%
4 Industrials 5.47%
5 Consumer Discretionary 4.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NFBK
826
DELISTED
Northfield Bancorp
NFBK
$120K 0.01%
12,309
-88
-0.7% -$965
GGN
827
GAMCO Global Gold, Natural Resources & Income Trust
GGN
$836M
$114K 0.01%
29,423
-1,175
-4% -$4.42K
NGM
828
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$112K 0.01%
70,636
+4,700
+7% +$6.97K
CAN
829
Canaan Creative
CAN
$150M
$106K 0.01%
69,858
-2,756
-4% -$4.67K
VLY icon
830
Valley National Bancorp
VLY
$8.16B
$106K 0.01%
13,261
-12,749
-49% -$114K
BTAI icon
831
BioXcel Therapeutics
BTAI
$28.8M
$105K 0.01%
2,338
+57
+2% +$2.72K
CX icon
832
Cemex
CX
$16.1B
$102K 0.01%
+11,320
New +$90.7K
PLTK icon
833
Playtika
PLTK
$1.02B
$100K 0.01%
14,212
-433
-3% -$3.19K
IRWD icon
834
Ironwood Pharmaceuticals
IRWD
$711M
$97.4K 0.01%
11,187
-87
-0.8% -$1.06K
HMY icon
835
Harmony Gold Mining
HMY
$12.2B
$96.1K 0.01%
+11,760
New +$75.1K
ATRA icon
836
Atara Biotherapeutics
ATRA
$80.6M
$82.6K ﹤0.01%
4,762
+317
+7% +$5.63K
PYN
837
DELISTED
PIMCO New York Municipal Income Fund III
PYN
$75K ﹤0.01%
12,773
-116,923
-90% -$691K
ARBK
838
Argo Blockchain
ARBK
$42.3M
$71.3K ﹤0.01%
152
-6
-4% -$2.83K
NVAX icon
839
Novavax
NVAX
$1.31B
$67.6K ﹤0.01%
14,135
+940
+7% +$4.36K
OPRT icon
840
Oportun Financial
OPRT
$350M
$50K ﹤0.01%
20,588
-812
-4% -$2.93K
A icon
841
Agilent Technologies
A
$42.2B
-1,707
Closed -$237K
ACP
842
abrdn Income Credit Strategies Fund
ACP
$641M
-29,272
Closed -$199K
APD icon
843
Air Products & Chemicals
APD
$68.9B
-3,879
Closed -$1.06M
CVSA
844
Covista Inc
CVSA
$4.31B
-3,915
Closed -$231K
BGB
845
Blackstone Strategic Credit 2027 Term Fund
BGB
$507M
-72,595
Closed -$822K
BGX
846
Blackstone Long-Short Credit Income Fund
BGX
$138M
-57,065
Closed -$653K
BNS icon
847
Scotiabank
BNS
$108B
-4,356
Closed -$212K
BSL
848
Blackstone Senior Floating Rate 2027 Term Fund
BSL
$170M
-20,319
Closed -$271K
CCI icon
849
Crown Castle
CCI
$31.3B
-1,798
Closed -$207K
CCRD
850
DELISTED
CoreCard
CCRD
-10,269
Closed -$142K

Similar funds

Hennion & Walsh Asset Management's Q1 2024 Portfolio in Review

As of Q1 2024, Hennion & Walsh Asset Management held 896 positions worth $1.87B, up 6.9% from $1.75B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Hennion & Walsh Asset Management's Q1 2024 filing shows 80 new, 374 increased, 377 reduced and 56 closed positions. Its largest new stake was Invesco S&P 500 Equal Weight ETF: 92,735 shares worth $15.7M. The largest sale was Vanguard Morningstar Value ETF, an estimated $20.2M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, down from 12% a quarter earlier, followed by Financials and Technology.

  • Hennion & Walsh Asset Management's largest Q1 2024 buy was Invesco S&P 500 Equal Weight ETF: 92,735 shares worth $15.7M.
  • Hennion & Walsh Asset Management added most to JPMorgan Equity Premium Income ETF in Q1 2024, an estimated $19.9M increase.
  • Hennion & Walsh Asset Management's biggest Q1 2024 reduction was Schwab US Dividend Equity ETF, cutting an estimated $17.5M.
  • Hennion & Walsh Asset Management fully exited Vanguard Morningstar Value ETF in Q1 2024, selling an estimated $20.2M.
  • Hennion & Walsh Asset Management's ten largest holdings make up 17% of its $1.87B portfolio in Q1 2024.
  • Hennion & Walsh Asset Management opened 80 new positions and closed 56 in Q1 2024.
  • Hennion & Walsh Asset Management's portfolio value rose 6.9% quarter-over-quarter to $1.87B.

Based on Hennion & Walsh Asset Management's 13F filing for Q1 2024, filed 17 Apr 2024.